Moreover, the results of in vitro cell culture and in vivo preclinical mouse model studies performed by Sun et al. [160] confirmed visfatin-mediated enhancement of prostate cancer invasiveness into muscle tissues. This evidence concerns the gene NAMPT and prostate carcinoma.